Fischer U - Search Results

1

Stable transgenic expression of IL-2 and HSV1-tk by single and fusion tumor cell lines bearing EWS/FLI-1 chimeric genes.

Staege MS, Gorelov V, Bulankin A, Fischer U, Dumon K, Hohndorf L, Hattenhorst U, Kramm C, Burdach S. Staege MS, et al. Among authors: fischer u. Pediatr Hematol Oncol. 2003 Mar;20(2):119-40. doi: 10.1080/0880010390158612. Pediatr Hematol Oncol. 2003. PMID: 12554523

2

A neuroblastoma-selective suicide gene therapy approach using the tyrosine hydroxylase promoter.

Steffens S, Sandquist A, Frank S, Fischer U, Lex C, Rainov NG, Kramm CM. Steffens S, et al. Among authors: fischer u. Pediatr Res. 2004 Aug;56(2):268-77. doi: 10.1203/01.PDR.0000132666.23103.EF. Epub 2004 Jun 4. Pediatr Res. 2004. PMID: 15181182

3

Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.

Frank S, Steffens S, Fischer U, Tlolko A, Rainov NG, Kramm CM. Frank S, et al. Among authors: fischer u. Cancer Gene Ther. 2002 Feb;9(2):178-88. doi: 10.1038/sj.cgt.7700422. Cancer Gene Ther. 2002. PMID: 11857036

4

Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells.

Fischer U, Steffens S, Frank S, Rainov NG, Schulze-Osthoff K, Kramm CM. Fischer U, et al. Oncogene. 2005 Feb 10;24(7):1231-43. doi: 10.1038/sj.onc.1208290. Oncogene. 2005. PMID: 15592511

5

Systemic activation of the immune system during ganciclovir treatment following intratumoral herpes simplex virus type 1 thymidine kinase gene transfer in an adolescent ependymoma patient.

Kramm CM, Korholz D, Rainov NG, Niehues T, Fischer U, Steffens S, Frank S, Banning U, Horneff G, Schroten H, Burdach S. Kramm CM, et al. Among authors: fischer u. Neuropediatrics. 2002 Feb;33(1):6-9. doi: 10.1055/s-2002-23592. Neuropediatrics. 2002. PMID: 11930269

6

Enhanced green fluorescent protein fusion proteins of herpes simplex virus type 1 thymidine kinase and cytochrome P450 4B1: applications for prodrug-activating gene therapy.

Steffens S, Frank S, Fischer U, Heuser C, Meyer KL, Dobberstein KU, Rainov NG, Kramm CM. Steffens S, et al. Among authors: fischer u. Cancer Gene Ther. 2000 May;7(5):806-12. doi: 10.1038/sj.cgt.7700173. Cancer Gene Ther. 2000. PMID: 10830728

7

MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program.

Viemann D, Barczyk K, Vogl T, Fischer U, Sunderkötter C, Schulze-Osthoff K, Roth J. Viemann D, et al. Among authors: fischer u. Blood. 2007 Mar 15;109(6):2453-60. doi: 10.1182/blood-2006-08-040444. Epub 2006 Nov 9. Blood. 2007. PMID: 17095618 Free article.

8

The tyrosine kinase Lck is a positive regulator of the mitochondrial apoptosis pathway by controlling Bak expression.

Samraj AK, Stroh C, Fischer U, Schulze-Osthoff K. Samraj AK, et al. Among authors: fischer u. Oncogene. 2006 Jan 12;25(2):186-97. doi: 10.1038/sj.onc.1209034. Oncogene. 2006. PMID: 16116473

9

Caspase-10 sensitizes breast carcinoma cells to TRAIL-induced but not tumor necrosis factor-induced apoptosis in a caspase-3-dependent manner.

Engels IH, Totzke G, Fischer U, Schulze-Osthoff K, Jänicke RU. Engels IH, et al. Among authors: fischer u. Mol Cell Biol. 2005 Apr;25(7):2808-18. doi: 10.1128/MCB.25.7.2808-2818.2005. Mol Cell Biol. 2005. PMID: 15767684 Free PMC article.

10

Many cuts to ruin: a comprehensive update of caspase substrates.

Fischer U, Jänicke RU, Schulze-Osthoff K. Fischer U, et al. Cell Death Differ. 2003 Jan;10(1):76-100. doi: 10.1038/sj.cdd.4401160. Cell Death Differ. 2003. PMID: 12655297 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,487 results

Search Page

Filters